| Patents for C07H 15 - Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals (17,975) |
|---|
| 01/29/2004 | US20040018963 O-derivatized nocathiacin derivatives |
| 01/29/2004 | CA2492941A1 Remedy |
| 01/28/2004 | EP1384999A1 Bacteriotoxin adsorbents and method of screening the same |
| 01/28/2004 | EP1384710A1 Synthesis of heterocyclic compounds containing five- or six-membered rings |
| 01/28/2004 | EP1383538A2 Oral absorbed drugs |
| 01/28/2004 | EP1383492A1 Molecular conjugates for use in treatment of cancer |
| 01/28/2004 | CN1136225C Supercritical CO2 extraction method for extracting glycyrrhizinic acid from licorice |
| 01/28/2004 | CN1136224C Inositolglycuns having insulin-like action |
| 01/27/2004 | US6683063 Lipopolysaccharide disorders |
| 01/27/2004 | US6683056 Synergistic mixture with antilipemic agent |
| 01/22/2004 | WO2004007709A2 Production of polyketides |
| 01/22/2004 | WO2004007516A1 Process for producing glycoside |
| 01/22/2004 | WO2004007515A1 Sulfotransferase inhibitors |
| 01/22/2004 | WO2004007514A1 Antimicrobial molecule |
| 01/22/2004 | WO2004007370A1 Simple process for production of zeolite analogues functioning as acid catalysts |
| 01/22/2004 | WO2003035657A3 Use of alkylpolyglycosides as emulsifying agents for the preparation of oil-in-water emulsions containing mineral pigments or fillers and the oil-in-water emulsions containing such alkylpolyglycosides |
| 01/22/2004 | US20040014683 Sugar-derived gellant for hydrogel formation |
| 01/22/2004 | US20040014682 Solvent extraction using alcohol; immunosuppressants; autoimmune diseases; rheumatic diseases |
| 01/22/2004 | US20040014642 Inositol pyrophosphates, and methods of use thereof |
| 01/22/2004 | DE19705664B4 Verfahren zur Herstellung 1,1-GPM angereicherter Phasen mit über 75 Gew.-% a.TS bis über 99 Gew.-% a.TS 1,1-GPM und 1,6-GPS angereicherter Phasen mit über 80 Gew.-% a.TS bis über 99 Gew.-% a.TS 1,6 GPS A process for producing 1,1-GPM-enriched phase with more than 75 wt .-% solid phase content to 99 wt .-% solid phase content of 1,1-GPM and 1,6-GPS-enriched phase with more than 80 wt .-% solid phase content up to 99 wt .-% solid phase content 1.6 GPS |
| 01/22/2004 | CA2492666A1 Antimicrobial molecule |
| 01/21/2004 | EP1382329A1 Compositions for photoprotection comprising a flavonoid |
| 01/21/2004 | EP1381361A1 Combination therapy comprising glucose reabsorption inhibitors and ppar modulators |
| 01/21/2004 | EP1015536B1 Cationic sugar surfactants from ethoxylated ammonium compounds and reducing saccharides |
| 01/21/2004 | EP0853627B1 Substituted liposaccharides useful in the treatment and prevention of endotoxemia |
| 01/21/2004 | CN1469757A Use of metal complexes containing perfluoroalkyl as contrast agents in MR-imaging for the representation of plaques, tumours and necroses |
| 01/21/2004 | CN1469711A Treatment of helicobacter with isothiocyanates |
| 01/21/2004 | CN1468858A Serial Lincomycin naprosyn salt |
| 01/21/2004 | CN1135223C Aryl-substd propanolamine derivate medicine containing them and their use |
| 01/20/2004 | US6680300 For cancer therapy |
| 01/15/2004 | WO2004005532A2 Solid-phase and solution-phase synthesis of glycosylphosphatidylinositol glycans |
| 01/15/2004 | WO2004005308A2 Processes for the production of aminoalkyl glucosaminide phosphate and disaccharide immunoeffectors, and intermediates therefor |
| 01/15/2004 | WO2004004746A1 Simmondsin for use as an angiogenesis inhibitor |
| 01/15/2004 | WO2004004646A2 O-derivatized nocathiacin derivatives |
| 01/15/2004 | CA2738235A1 Processes for the production of aminoalkyl glucosaminide phosphate and disaccharide immunoeffectors, and intermediates therefor |
| 01/15/2004 | CA2492446A1 Processes for the production of aminoalkyl glucosaminide phosphate and disaccharide immunoeffectors, and intermediates therefor |
| 01/15/2004 | CA2491074A1 O-derivatized nocathiacin derivatives |
| 01/14/2004 | EP1379676A2 Process for the preparation of 2-hydroxymethyl-pyrolidine-3,4-diols |
| 01/14/2004 | EP1379247A1 Agent for topical ophthalmic treatment of ocular inflammatory diseases |
| 01/14/2004 | CN1468234A Perfluoroalkyl-containing complexes with sugar radicals, process for their production and their use |
| 01/14/2004 | CN1134449C Process for preparation of moenomycin A |
| 01/13/2004 | US6677435 Includes an active therapeutic agent joined to a blocking moiety sensitive to the catalytic action of molecules having retro- aldol and retro-michael catalytic activity; antitumor; anticarcinogenic agents |
| 01/13/2004 | US6677309 Anthracycline derivatives |
| 01/13/2004 | US6677163 Simple and durable immobilization of biomolecules |
| 01/13/2004 | CA2096309C Process for producing hydroxyalkyl glucosides |
| 01/08/2004 | WO2004002403A2 Sterols bearing pendant allosteric effectors of hemoglobin, and uses thereof |
| 01/08/2004 | WO2003064378A3 Novel compounds that inhibit factor xa activity |
| 01/08/2004 | US20040005649 Monoclonal antibody for monitoring and treating changes in tumor growth or metastasis |
| 01/07/2004 | EP1378241A1 Pharmaceutical compositions comprising arsenic for the treatment of melanoma |
| 01/07/2004 | EP1378240A2 Pharmaceutical compositions comprising arsenic for the treatment of multiple myeloma |
| 01/07/2004 | EP1261614B1 Method for the production of perbenzylated 1-o glycosides |
| 01/07/2004 | CN1466594A Polysaccharides with antithrombotic activity comprising at least a covalent bono with biotin or a biotin derivative |
| 01/07/2004 | CN1466590A Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same |
| 01/06/2004 | US6673907 Methods and compositions for the manufacture of C-3′ and C-4′ anthracycline antibiotics |
| 01/02/2004 | EP1374875A2 Pharmaceutical compositons comprising arsenic for the treatment of myelodysplastic syndrome |
| 01/02/2004 | EP1373288A1 Process for the preparation of 2'-halo-beta-l-arabinofuranosyl nucleosides |
| 01/02/2004 | EP1372670A1 Caloporoside derivatives, methods for the production thereof and their use |
| 01/01/2004 | US20040002597 Catalytic process for the modification of carbohydrates, alcohols, aldehydes or polyhydroxy compounds |
| 01/01/2004 | US20040002463 Inhibitors and methods of use thereof |
| 12/31/2003 | WO2004000863A1 Produrg, medicinal utilization thereof and process for producing the same |
| 12/31/2003 | WO2004000862A1 Fatty acid esters of ethoxylated alkylglucosides |
| 12/31/2003 | WO2004000861A1 Process for producing crystalline maltitol |
| 12/31/2003 | WO2003089577A3 Antihelminthic anthraquinones and method of use thereof |
| 12/31/2003 | WO2002069704A8 Devices and methods for eliminating termite colonies |
| 12/31/2003 | CN1463977A Process for extracting amygdalin and use thereof |
| 12/31/2003 | CN1132840C Stevioside glycoside refining process |
| 12/31/2003 | CA2490626A1 Prodrug, medicinal utilization thereof and process for producing the same |
| 12/30/2003 | US6670398 Compounds and methods for treating transplant rejection |
| 12/30/2003 | US6670361 Anticancer agents |
| 12/30/2003 | US6670338 Pentasaccharides processes for their preparation and pharmaceutical compositions containing them |
| 12/30/2003 | CA2076063C Sulfated glycosaminoglycanoid derivatives |
| 12/25/2003 | US20030235614 Time release agents comprising drugs such as tacrolimus in solid solutions |
| 12/24/2003 | WO2003106474A2 Gangliosides with a modified acyl function |
| 12/24/2003 | WO2003106473A1 1-carboxymethyl analogues of glucosyl lipid a |
| 12/24/2003 | WO2003106413A2 Process for the preparation of oxazolidinones and method of use thereof |
| 12/24/2003 | WO2003106395A1 Devices and methods for eliminating termite colonies |
| 12/24/2003 | WO2003105847A1 Ophthalmic compositions for treating ocular hypertension |
| 12/24/2003 | WO2003105769A2 Synthetic c-glycolipid and its use for treating cancer infectious diseases and autoimmune diseases |
| 12/24/2003 | WO2003105756A2 Stereoselective synthesis of 1,2-disubstituted cycloalkyls |
| 12/24/2003 | WO2003105580A1 Devices and methods for eliminating termite colonies |
| 12/24/2003 | WO2003070182A3 Sodium channel blockers |
| 12/24/2003 | CN1462750A Erigeron ester B and its preparation method as well as application in pharmacy |
| 12/24/2003 | CA2488802A1 Ophthalmic compositions for treating ocular hypertension |
| 12/24/2003 | CA2464109A1 Process for the preparation of oxazolidinones and method of use thereof |
| 12/23/2003 | US6667396 Polyxyloside derivatives, process for preparing them, composition containing them and use as surfactants |
| 12/23/2003 | US6667161 Chromogenic substrates of sialidase of bacterial, viral, protozoa, and vertebrate origin and methods of making and using the same |
| 12/18/2003 | WO2003104473A2 Galactosyl isomalt, method for production and use thereof |
| 12/18/2003 | WO2003104248A2 Derivatives of uronic (alkyl-d-mannopyranoside) acid, methods for the preparation thereof, and applications thereof |
| 12/18/2003 | WO2003104247A2 Treatment of congenital disorders of glycosylation (cdg) using mannose |
| 12/18/2003 | US20030232766 Combinatorial libraries of monosaccharides |
| 12/18/2003 | US20030232452 Linkers for synthesis of oligosaccharides on solid supports |
| 12/18/2003 | US20030232102 Total glycosides of paeony, method to prepare the same and uses thereof |
| 12/18/2003 | CA2490037A1 Galactosyl isomalt, a method for producing it and its use |
| 12/17/2003 | EP1370673A1 Topoisomerase i selective cytotoxic sugar derivatives of indolopyrrolocarbazoles |
| 12/17/2003 | EP1370573A2 Low molecular serine protease inhibitors comprising polyhydroxy-alkyl and polyhydroxy-cycloalkyl radicals |
| 12/17/2003 | EP1370570A2 Plasma glucosylceramide deficiency as risk factor for thrombosis and modulator of anticoagulant protein c |
| 12/17/2003 | EP1370566A1 Synthetic derivatives of 21-butenyl and related spinosyns |
| 12/17/2003 | EP0646122B1 An improved process for the preparation of alkyl glycosides |
| 12/17/2003 | CN1131224C Luteolin and method for preparationg luteolin derivatives |
| 12/16/2003 | US6664399 Linkage less susceptible to hydrolysis |